Bradykinin Receptor Antagonism During Cardiopulmonary Bypass

Clinical trial NCT00223704 · COMPLETED

Trial details

NCT number: NCT00223704
Sponsor: Vanderbilt University
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Cardiopulmonary Bypass Inflammation Fibrinolysis Surgery

Start date: 2006-05-01
Primary completion: 2012-06-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.